July 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan ~1 min.According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....
March 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation ~2 min.Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....
March 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results ~2 min.Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....
March 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry ~1 min.Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....
March 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry ~2 min.Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....
March 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry? ~2 min.Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....
March 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study ~1 min.Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....
February 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion ~1 min.Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....
February 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development ~1 min.Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....
February 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings ~2 min.ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....
April 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis ~1 min.In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....
August 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62% ~1 min.REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform....
February 23, 2024ABBBVIE INC. Hits Price Target Forecast with 11.34% Profit Margin ~2 min.On April 25, 2023, QuantWave issued a long forecast signal for ABBVIE INC. with a price of $151.6. Fast forward to February 23, 2024, the stock reached the predicted target price of $168....
May 1, 2023ELI LILLY AND COMPANY Stock Hits Forecast Price Target with a Profit of 26.14% ~2 min.On July 1, 2022, QuantWave's forecast signal for ELI LILLY AND COMPANY stock indicated a long position at a price of 316.33 $....
July 30, 2024QuantWave Achieves 17.27% Profit Target for VERTEX PHARMACEUTICALS INCORPORATED ~1 min.QuantWave, the automated forecasting platform, has successfully hit its price target forecast for VERTEX PHARMACEUTICALS INCORPORATED, resulting in a profitable return of 17.27%....
